Superparamagnetic nanovector with anti-cancer properties: γFe2O3@Zoledronate

Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo

Franz Scherer, Martina Anton, Ulrike Schillinger et al. · Gene Therapy · 2002 · 926 citations

Pharmacy, Bioengineering, Biotechnology +14

Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite

George H. Nancollas, Ruikang Tang, Roger Phipps et al. · Bone · 2005 · 859 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

S.M. Zeisberger, B Odermatt, Cornelia Marty et al. · British Journal of Cancer · 2006 · 615 citations · Full text

Medicine, Oncology, Pharmacology +17

Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.

S. Boissier, Mercedes Ferreras, Olivier Peyruchaud et al. · PubMed · 2000 · 573 citations

Medicine, Oncology, Pharmacology +17

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

Lee S. Rosen, David Gordon, William Dugan et al. · Cancer · 2003 · 334 citations · Full text

Medicine, Oncology, Bone Metabolism +14